tiprankstipranks

Barbara Gayle Duncan Insider Profile

4 Followers
Barbara Gayle Duncan, CFO at Intercept Pharma, holds 24.89K shares in Intercept Pharma (Ticker: ICPT), holds ― shares in Adaptimmune Therapeutics (Ticker: ADAP), holds 0.00 shares in Innoviva (Ticker: INVA). Most recently, Barbara Gayle Duncan Sold ― shares of Intercept Pharma on Oct 05, 2016 for an estimated value of 23.99K.
tipranks
Barbara Gayle Duncan

Barbara Gayle Duncan
Intercept Pharma (ICPT)
CFO

Ranked #9,412 out of 99,335 Corporate Insiders

Profitable Transactions

86%
6 out of 7 Profitable Transactions

Average Return

+24.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$826K
87.31%
12.69%
0.00%
0.00%
0.00% Others
A breakdown of Barbara Gayle Duncan's holdings

Insider Roles

Halozyme
(HALO)
Director
Atea Pharmaceuticals
(AVIR)
Director
Adaptimmune Therapeutics
(ADAP)
Director
Innoviva
(INVA)
Director
+1 other positions
Roles that Barbara Gayle Duncan holds in companies

Most Profitable Insider Trade

Stock:
Intercept Pharma
(ICPT)
Rating:Informative Sell
Date:Apr 01, 2015 - Apr 01, 2016
Return:+52.70%
The most profitable trade made by Barbara Gayle Duncan

Barbara Gayle Duncan's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ICPT
Intercept Pharma
Oct 05, 2016
Informative Sell
23.99K
$472.95K
Adaptimmune Therapeutics
Director
Innoviva
Apr 24, 2017
Director
Uninformative Buy
$0.00
JNCE
Jounce Therapeutics
$0.00
Ovid Therapeutics
Director
IMMU
Immunomedics
Oct 23, 2020
Uninformative Sell
$0.00
Atea Pharmaceuticals
Jun 18, 2024
Director
Uninformative Buy
119.67K
$104.75K
FUSN
Fusion Pharmaceuticals
Halozyme
Apr 29, 2024
Director
Uninformative Buy
$720.90K
GNMX
Aevi Genomic Medicine
Oct 18, 2017
Informative Buy
75.00K
$0.00
List of latest transactions for each holding click on a transaction to see Barbara Gayle Duncan's performance on stock

Barbara Gayle Duncan insider profile FAQ

What is the percentage of profitable transactions made by Barbara Gayle Duncan?
The percentage of profitable transactions made by Barbara Gayle Duncan is 86%.
    What is the average return per transaction made by Barbara Gayle Duncan?
    The average return per transaction made by Barbara Gayle Duncan is 24.90%.
      What stocks does Barbara Gayle Duncan hold?
      Barbara Gayle Duncan holds: ICPT, ADAP, INVA, JNCE, OVID, IMMU, AVIR, FUSN, HALO, GNMX stocks.
        What was Barbara Gayle Duncan’s latest transaction?
        Barbara Gayle Duncan latest transaction was an Informative Sell of $23.99K.
          What was Barbara Gayle Duncan's most profitable transaction?
          Barbara Gayle Duncan’s most profitable transaction was an Informative Sell of ICPT stock on April 1, 2015. The return on the trade was 52.70%.
            What is Barbara Gayle Duncan's role in Intercept Pharma?
            Barbara Gayle Duncan's role in Intercept Pharma is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.